A serendipitous lab discovery led to a breakthrough vaccine for a fatal tick-borne disease. Now investors are sought to take it commercial.
Dr. Shimon Harrus did not intend to find the world’s first vaccine against canine monocytic ehrlichiosis (CMT), a sometimes fatal tick-borne disease in dogs. Instead, he was attempting to determine how long ticks must be attached to a dog’s fur in order to transmit CMT.
“I was using bacteria I cultured in my lab, and all of a sudden I realized the two dogs in our experiment did not become sick, and the ticks I put on the dogs did not become infected,” Harrus tells ISRAEL21c. “Then we performed a big study and we realized something important was going on.”
Continue reading at Israel21C.